Sex Differences in Clinical Characteristics and Outcomes of Patients with SARS-CoV-2-Infection Admitted to Intensive Care Units in Austria.
COVID-19
ICU
diabetes
gender
mortality
sex
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
23 Mar 2022
23 Mar 2022
Historique:
received:
23
02
2022
revised:
16
03
2022
accepted:
17
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
A male predominance is reported in hospitalised patients with COVID-19 alongside a higher mortality rate in men compared to women. To assess if the reported sex bias in the COVID-19 pandemic is validated by analysis of a subset of patients with severe disease. A nationwide retrospective cohort study was performed using the Austrian National COVID Database. We performed a sex-specific Lasso regression to select the covariates best explaining the outcomes of mechanical ventilation and death using variables known before ICU admission. We use logistic regression to construct a sex-specific "risk score" for the outcomes using these variables. We studied the characteristics and outcomes of patients admitted to intensive care units (ICUs) in Austria. 5118 patients admitted to the ICU in Austria with a COVID-19 diagnosis in 03/2020-03/2021. Demographic and clinical characteristics, vital signs and laboratory tests, comorbidities, and management of patients admitted to ICUs were analysed for possible sex differences. The aim was to define risk scores for mechanical ventilation and mortality for each sex to provide better sex-sensitive management and outcomes in the future. We found balanced accuracies between 55% and 65% to predict the outcomes. Regarding outcome death, we found that the risk score for pre-ICU variables increases with age, renal insufficiency (f: OR 1.7(2), m: 1.9(2)) and decreases with observance as admission cause (f: OR 0.33(5), m: 0.36(5)). Additionally, the risk score for females also includes respiratory insufficiency (OR 2.4(4)) while heart failure for males only (OR 1.5(1)). Better knowledge of how sex influences COVID-19 outcomes at ICUs will have important implications for the ongoing pandemic's clinical care and management strategies. Identifying sex-specific features in individuals with COVID-19 and fatal consequences might inform preventive strategies and public health services.
Identifiants
pubmed: 35455633
pii: jpm12040517
doi: 10.3390/jpm12040517
pmc: PMC9026885
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Austrian Science Fund FWF
ID : I 4209
Pays : Austria
Références
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355
pubmed: 32667669
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Open Forum Infect Dis. 2021 Aug 31;8(9):ofab448
pubmed: 34584899
J Trauma. 2011 Oct;71(4):878-83; discussion 883-5
pubmed: 21986736
Biol Sex Differ. 2021 Feb 5;12(1):20
pubmed: 33546750
PLoS One. 2020 Oct 6;15(10):e0237297
pubmed: 33022004
Crit Care. 2015 Mar 30;19:129
pubmed: 25887421
Anaesthesia. 2020 Oct;75(10):1340-1349
pubmed: 32602561
Neuroendocrinology. 2021;111(11):1066-1085
pubmed: 33242856
Biol Sex Differ. 2020 May 25;11(1):29
pubmed: 32450906
Eur J Endocrinol. 2021 Oct 08;185(5):C13-C17
pubmed: 34516392
Anaesthesia. 2021 Sep;76(9):1224-1232
pubmed: 34189735
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27285-27291
pubmed: 33060298
JAMA Netw Open. 2020 Jun 1;3(6):e2012270
pubmed: 32543702
Nat Commun. 2020 Dec 9;11(1):6317
pubmed: 33298944
Diabetes Obes Metab. 2021 Feb;23(2):589-598
pubmed: 33200501
Lancet Diabetes Endocrinol. 2020 Jul;8(7):562-564
pubmed: 32437642
J Clin Med. 2021 Oct 26;10(21):
pubmed: 34768473
Crit Care Med. 2022 Jan 1;50(1):e1-e10
pubmed: 34374504
Ann Intensive Care. 2019 Mar 29;9(1):43
pubmed: 30927096
Nat Rev Immunol. 2020 Jul;20(7):442-447
pubmed: 32528136
J Clin Invest. 2020 Nov 2;130(11):6141-6150
pubmed: 32764200
Biol Sex Differ. 2020 Oct 16;11(1):57
pubmed: 33066823
Eur J Endocrinol. 2021 Jul 05;185(2):299-311
pubmed: 34085949